• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison of Clinical Symptoms and Cardiac Lesions in Children with Typical and Atypical Kawasaki Disease.典型与非典型川崎病患儿临床症状及心脏病变的比较
Med Sci (Basel). 2019 Apr 18;7(4):63. doi: 10.3390/medsci7040063.
2
Kawasaki disease in children and adolescents: clinical data of Kawasaki patients in a western region (Tyrol) of Austria from 2003-2012.儿童及青少年川崎病:2003年至2012年奥地利西部地区(蒂罗尔州)川崎病患者的临床资料
Pediatr Rheumatol Online J. 2014 Sep 2;12(1):37. doi: 10.1186/1546-0096-12-37.
3
Kawasaki disease in Sicily: clinical description and markers of disease severity.西西里岛的川崎病:临床描述与疾病严重程度标志物
Ital J Pediatr. 2016 Nov 2;42(1):92. doi: 10.1186/s13052-016-0306-z.
4
Clinical and epidemiological characteristics of kawasaki disease.川崎病的临床与流行病学特征
Jundishapur J Microbiol. 2014 Aug;7(8):e11014. doi: 10.5812/jjm.11014. Epub 2014 Jul 27.
5
[Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].N末端脑钠肽前体预测川崎病冠状动脉病变风险
Zhonghua Er Ke Za Zhi. 2015 Apr;53(4):300-3.
6
Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.川崎病患者早期静脉注射免疫球蛋白治疗。
J Pediatr. 2002 Apr;140(4):450-5. doi: 10.1067/mpd.2002.122469.
7
Clinical and laboratory features and disease outcome of kawasaki disease: the analysis of our experience and literature review.川崎病的临床和实验室特征及疾病转归:我们的经验分析和文献复习。
J Clin Rheumatol. 1997 Oct;3(5):241-7. doi: 10.1097/00124743-199710000-00002.
8
[Clinical analysis of 942 cases of Kawasaki disease].942例川崎病临床分析
Zhonghua Er Ke Za Zhi. 2006 May;44(5):324-8.
9
Atypical recurrent Kawasaki disease with retropharyngeal involvement: A case study and literature review.伴有咽后受累的非典型复发性川崎病:病例报告及文献综述
Ann Pediatr Cardiol. 2020 Jul-Sep;13(3):244-247. doi: 10.4103/apc.APC_89_19. Epub 2020 Jun 11.
10
Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.伴有严重心脏后遗症的川崎病:新西兰近期经验教训
J Paediatr Child Health. 2004 Sep-Oct;40(9-10):524-9. doi: 10.1111/j.1440-1754.2004.00456.x.

引用本文的文献

1
Kawasaki Disease and Systemic Juvenile Idiopathic Arthritis - Two Ends of the Same Spectrum.川崎病与全身型幼年特发性关节炎——同一谱系的两端。
Front Pediatr. 2021 Apr 28;9:665815. doi: 10.3389/fped.2021.665815. eCollection 2021.
2
A case report of atypical Kawasaki disease presented with severe elevated transaminases and literature review.一份以严重升高的转氨酶为表现的非典型川崎病病例报告及文献复习。
BMC Infect Dis. 2021 May 4;21(1):415. doi: 10.1186/s12879-021-06101-y.
3
Multisystem inflammatory syndrome in pediatric COVID-19 patients: a meta-analysis.儿童 COVID-19 患者中的多系统炎症综合征:一项荟萃分析。
World J Pediatr. 2021 Apr;17(2):141-151. doi: 10.1007/s12519-021-00419-y. Epub 2021 Feb 20.
4
Kawasaki disease in siblings in close temporal proximity to each other-what are the implications?兄弟姐妹在短时间内相继患川崎病——这意味着什么?
Clin Rheumatol. 2021 Mar;40(3):849-855. doi: 10.1007/s10067-020-05328-5. Epub 2020 Aug 10.
5
Kawasaki disease: Clinico-laboratory spectrum and outcome in a cohort of children treated at a tertiary care hospital in Islamabad, Pakistan.川崎病:在巴基斯坦伊斯兰堡一家三级医疗医院接受治疗的一组儿童的临床实验室特征及预后
Pak J Med Sci. 2020 Jan-Feb;36(2):260-264. doi: 10.12669/pjms.36.2.910.
6
Unusual Presentation Of Kawasaki Disease With Gastrointestinal And Renal Manifestations.川崎病伴胃肠道和肾脏表现的不典型呈现
Ther Clin Risk Manag. 2019 Dec 5;15:1411-1416. doi: 10.2147/TCRM.S226624. eCollection 2019.

本文引用的文献

1
Melatonin: A hypothesis for Kawasaki disease treatment.褪黑素:川崎病治疗的假说。
Med Hypotheses. 2018 Oct;119:6-10. doi: 10.1016/j.mehy.2018.07.010. Epub 2018 Jul 17.
2
Influence of Latitude on the Prevalence of Kawasaki Disease: A Retrospective Cohort Study from the Taiwan National Health Insurance Database and Review of the Literature.纬度对川崎病患病率的影响:来自台湾全民健康保险数据库的回顾性队列研究及文献复习。
Int J Environ Res Public Health. 2018 Apr 25;15(5):845. doi: 10.3390/ijerph15050845.
3
Risk Factors Related to Coronary Artery Outcome in Kawasaki Disease.川崎病冠状动脉病变的相关危险因素
Korean Circ J. 2018 Apr;48(4):329-331. doi: 10.4070/kcj.2018.0077.
4
Laboratory Markers in Incomplete Kawasaki Disease according to Coronary Artery Outcome.根据冠状动脉转归情况分析不完全川崎病的实验室指标
Korean Circ J. 2018 Apr;48(4):287-295. doi: 10.4070/kcj.2017.0342.
5
Serum Levels of Syndecan-1 in Patients With Kawasaki Disease.川崎病患者血清 syndecan-1 水平。
Pediatr Infect Dis J. 2019 Jan;38(1):89-94. doi: 10.1097/INF.0000000000002047.
6
The global epidemiology of Kawasaki disease: Review and future perspectives.川崎病的全球流行病学:综述与未来展望
Glob Cardiol Sci Pract. 2017 Oct 31;2017(3):e201720. doi: 10.21542/gcsp.2017.20.
7
Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution.川崎病的环境流行病学:关联疾病病因、发病机制与全球分布
PLoS One. 2018 Feb 7;13(2):e0191087. doi: 10.1371/journal.pone.0191087. eCollection 2018.
8
Clinical Presentation and Cardiovascular Outcome in Complete versus Incomplete Kawasaki Disease.完全性与不完全性川崎病的临床表现及心血管结局
Indian Pediatr. 2017 Oct 15;54(10):844-847. doi: 10.1007/s13312-017-1147-6. Epub 2017 Jul 11.
9
Coronary Artery Aneurysms: A Review of the Epidemiology, Pathophysiology, Diagnosis, and Treatment.冠状动脉瘤:流行病学、病理生理学、诊断及治疗综述
Front Cardiovasc Med. 2017 May 5;4:24. doi: 10.3389/fcvm.2017.00024. eCollection 2017.
10
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.川崎病的诊断、治疗和长期管理:美国心脏协会发布的一份面向医疗保健专业人员的科学声明。
Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29.

典型与非典型川崎病患儿临床症状及心脏病变的比较

Comparison of Clinical Symptoms and Cardiac Lesions in Children with Typical and Atypical Kawasaki Disease.

作者信息

Behmadi Maryam, Alizadeh Behzad, Malek Abdolreza

机构信息

Department of Pediatric Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 99191-91778, Iran.

Pediatric and Congenital Cardiology Division, Department of Pediatric Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 99191-91778, Iran.

出版信息

Med Sci (Basel). 2019 Apr 18;7(4):63. doi: 10.3390/medsci7040063.

DOI:10.3390/medsci7040063
PMID:31003567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6524055/
Abstract

The present study was performed to evaluate the clinical symptoms and cardiovascular complications in patients with typical and atypical Kawasaki disease (KD). This retrospective study was conducted on the medical records of 176 patients with KD for three years. The study population was divided into two groups of typical and atypical based on the KD clinical criteria. The two groups were compared in terms of demographic data, clinical symptoms, cardiac lesions, and laboratory markers. Based on the diagnostic criteria, 105 (60%) and 71 (40%) patients were diagnosed with typical and atypical KD, respectively. The mean age of the typical patients (38.16 months) was higher than that of the atypical group (24.03 months) at the time of diagnosis ( < 0.05). The results revealed no significant difference between the two groups regarding the seasonal distribution of KD onset ( = 0.422). However, the most common season for the diagnosis of the disease was spring, followed by winter. There was no significant difference between the two groups in terms of fever duration ( = 0.39). Furthermore, vomiting was more common in the atypical patients than in the typical group ( = 0.017). In terms of the cardiac lesions, ectasia ( = 0.005) and lack of tapering of the distal coronary vessels ( = 0.015) were more frequently detected in the atypical group than in the typical group. Considering the laboratory findings, thrombocytosis ( = 0.010) and anemia ( = 0.048) were more common in the atypical group, compared to those in the typical group. On the other hand, the typical group had a higher serum alanine aminotransferase level (adjusted for age) ( = 0.012) and Hyponatremia (serum sodium concentration ≤130 mmol/L) ( = 0.034). Based on the findings of the current study, the fever duration from onset to diagnosis was slightly more in atypical KD patients than in the typical group, but not statistically significant, possibly due to more timely diagnosis of atypical KD. There was no difference in coronary aneurysm between the two groups at the time of diagnosis. The atypical group had a higher frequency of coronary ectasia and lack of tapering, indicating cardiac involvement. Consequently, these conditions should be given more attention in the atypical patients. Furthermore, the higher frequency of anemia and thrombocytosis in the atypical patients can be useful for diagnosis of this kind of KD.

摘要

本研究旨在评估典型和非典型川崎病(KD)患者的临床症状和心血管并发症。这项回顾性研究对176例KD患者的病历进行了为期三年的分析。根据KD临床标准,将研究人群分为典型和非典型两组。比较两组的人口统计学数据、临床症状、心脏病变和实验室指标。根据诊断标准,分别有105例(60%)和71例(40%)患者被诊断为典型和非典型KD。诊断时,典型患者的平均年龄(38.16个月)高于非典型组(24.03个月)(P<0.05)。结果显示,两组KD发病的季节分布无显著差异(P=0.422)。然而,该病最常见的诊断季节是春季,其次是冬季。两组发热持续时间无显著差异(P=0.39)。此外,非典型患者呕吐比典型组更常见(P=0.017)。在心脏病变方面,非典型组比典型组更频繁地检测到冠状动脉扩张(P=0.005)和远端冠状动脉血管无逐渐变细(P=0.015)。考虑实验室检查结果,非典型组血小板增多症(P=0.010)和贫血(P=0.048)比典型组更常见。另一方面,典型组血清丙氨酸转氨酶水平(校正年龄后)更高(P=0.012),低钠血症(血清钠浓度≤130 mmol/L)更常见(P=0.034)。根据本研究结果,非典型KD患者从发病到诊断的发热持续时间比典型组略长,但无统计学意义,可能是由于非典型KD诊断更及时。两组诊断时冠状动脉瘤无差异。非典型组冠状动脉扩张和无逐渐变细的频率更高,提示心脏受累。因此,在非典型患者中应给予更多关注。此外,非典型患者贫血和血小板增多症的较高频率有助于此类KD的诊断。